The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Clopoat CLOPOAT ACNE-CLEARING SPOT
Colloidal Sulfur · SULFUR 3 g/1 · Cream · Topical · Guangzhou Meixi Biotechnology Co., Ltd.
NDC 84167-0837-17 · 1 BAG in 1 BOX / 1 CREAM in 1 BAG · OTC MONOGRAPH DRUG · View full market →
Medicare Part D
Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- M006
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Colloidal Sulfur (Cream)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Guangzhou Meixi Biotechnology Co., Ltd. | SULFUR 3 g/1 | Jul 15, 2026 | Sep 2, 2026 |
| Guangzhou Meixi Biotechnology Co., Ltd. | UNDECYLENIC ACID 15 g/1; ZINC UNDECYLENATE 10 g/1 | Aug 12, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Clopoat CLOPOAT ACNE-CLEARING SPOT — NDC 84167-0837-17," retrieved September 3, 2026, https://drugdashboards.com/drug/84167083717.
Free to cite with attribution — see how the data is put together.